Key Segmentation:
By Type
-
Immunoglobulin Diagnostic Tests
-
C-Reactive Protein Diagnostic Tests
-
Free Light Chain Diagnostic Tests
-
Complement System Protein Tests
-
Pre-Albumin Tests
-
Haptoglobin Tests
-
Others
By Technology
-
ELISA
-
Chemiluminescence Immunoassay (CLIA)
-
Radioimmunoassay (RIA)
-
Immunoturbidity Assay
-
Immunoprotein Electrophoresis
-
Others
By Application
-
Infectious Disease Testing
-
Autoimmune Disease Testing
-
Oncology Testing
-
Allergy Testing
-
Endocrine Testing
-
Cardiovascular Testing
-
Others
By End User
-
Hospitals & Clinical Laboratories
-
Diagnostic Centres
-
Academic & Research Institutes
-
Pharmaceutical & Biotechnology Companies
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization:
With the given market data SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The market is expected to grow at a CAGR of 7.54% from 2026 to 2035.
The market was valued at USD 10.28 Billion in 2025.
Rising incidence of chronic diseases, autoimmune disorders, and hematological malignancies requiring consistent immunoprotein biomarker monitoring.
Immunoglobulin Diagnostic Tests dominated the market with 28.15% share in 2025.
North America dominated the market in 2025.